Data Sheet 2_KAE ameliorates LPS-mediated acute lung injury by inhibiting PANoptosis through the intracellular DNA-cGAS-STING axis.pdf by Yonghu Chen (2040136)

“…</p>Results<p>KAE significantly alleviated lipopolysaccharide-induced pulmonary injury by reducing inflammatory cell infiltration, alleviating pulmonary edema, enhancing antioxidant capacity, and decreasing levels of inflammatory cytokines in mouse lung tissues. …”

Data Sheet 1_KAE ameliorates LPS-mediated acute lung injury by inhibiting PANoptosis through the intracellular DNA-cGAS-STING axis.zip by Yonghu Chen (2040136)

“…</p>Results<p>KAE significantly alleviated lipopolysaccharide-induced pulmonary injury by reducing inflammatory cell infiltration, alleviating pulmonary edema, enhancing antioxidant capacity, and decreasing levels of inflammatory cytokines in mouse lung tissues. …”

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990 to 2021 (in Thousands). by Xinyue Qi (9637055)

Subjects:

Data Sheet 3_IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3.pdf by Huiyue Dong (4808436)

“…Background<p>Cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway is a cytosolic DNA sensor system. …”

Data Sheet 1_IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3.pdf by Huiyue Dong (4808436)

“…Background<p>Cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway is a cytosolic DNA sensor system. …”

Data Sheet 2_IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3.pdf by Huiyue Dong (4808436)

“…Background<p>Cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway is a cytosolic DNA sensor system. …”

PD-1 deficiency does not significantly impact the pathogen load and pathology following <i>S</i>. <i>japonicum</i> infection. by Liaoxun Lu (179293)

Subjects:

Systemic c-MET inhibition leads to decreased lesion size and inflammation during <i>L</i>. <i>mexicana</i> infection. by Katiuska Passelli (11965496)

Subjects:

Numbers of deaths, mortality rates, and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Disability-adjusted life years (DALYs), age-standardized DALY rates (ASDR), and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Numbers of deaths and disability-adjusted life years (DALYs) by disease stage in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Deaths and DALYs from hepatitis B-related liver diseases in 1990 and 2021 and their change trends from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific DALYs rate. by Xinyue Qi (9637055)

Subjects:

Contribution of acute hepatitis B, cirrhosis and other chronic diseases due to hepatitis B and liver cancer due to hepatitis B to deaths and DALYs of total liver diseases due to he... by Xinyue Qi (9637055)

Subjects:

Mortality rates and disability-adjusted life years (DALYs) rates by disease stage, sex, and age groups (<35, 35–49, 50–69, ≥ 70, and all ages) in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Temporal trends of mortality of the total burden related to hepatitis B and three disease stages for all ages and across four age groups (<35, 35–49, 50–69, and ≥ 70 years) from 19... by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific death rates in 2021. by Xinyue Qi (9637055)

Subjects:

Age-standardized mortality rates (ASMR), age-standardized disability-adjusted life year rates (ASDR), and their 95% uncertainty intervals (UIs) by disease stage in China from 1990... by Xinyue Qi (9637055)

Subjects:

BAPC model projections of mortality and DALYs rates for each disease stage in China from 2022 to 2035, with 50%, 60%, 70%, 80%, and 95% uncertainty intervals. by Xinyue Qi (9637055)

Subjects:

Temporal trends of DALYs of the total burden related to hepatitis B and three disease stages for all ages and across four age groups (<35, 35–49, 50–69, and ≥70 years) from 1990 to... by Xinyue Qi (9637055)

Subjects: